S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

STFS Star Fashion Culture Holdings Ltd

0.94

0.00 (0.00%)

Pre Market

Last Updated: 03:02:45

Delayed by 15 minutes

Form 424B4 - Prospectus [Rule 424(b)(4)]

Article too big to display. Click here to view on the SEC website

Star Fashion Culture (NASDAQ:STFS)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Star Fashion Culture Charts.

Star Fashion Culture (NASDAQ:STFS)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Star Fashion Culture Charts.

Star Fashion Culture Holdings Ltd News

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 30 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Form NT 20-F - Notification of inability to timely file Form 20-F
Thursday 31 October 2024 (5 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 21 October 2024 (5 months ago) • Edgar (US Regulatory)

WestPark Capital Announces Closing of $8.6 Million IPO for Star Fashion Culture Holdings Limited (NASDAQ:STFS)
Wednesday 16 October 2024 (5 months ago) • Business Wire

Star Fashion Culture Holdings Limited Announces Closing of $8.6 Million Initial Public Offering
Tuesday 15 October 2024 (5 months ago) • GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]
Tuesday 15 October 2024 (5 months ago) • Edgar (US Regulatory)

Star Fashion Culture Holdings Limited Announces Pricing of $8.60 Million Initial Public Offering
Friday 11 October 2024 (5 months ago) • GlobeNewswire Inc.

More Star Fashion Culture Holdings Ltd News Articles

Liquidmetal Technologies (QB)

TPT Global Tech (PK)

Cann American (CE)

Accredited Solutions (PK)

Bioelectronics (PK)

Lightwave Logic

Anavex Life Sciences

TransCode Therapeutics

Rennova Health (CE)

Fannie Mae (QB)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions